These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

155 related items for PubMed ID: 3403200

  • 1. Long-term effects of steroid and cytostatic treatment on the clinical course of idiopathic membranous glomerulonephritis (retrospective study).
    Mohácsi G, Magori A, Sonkodi S.
    Int Urol Nephrol; 1988; 20(3):315-25. PubMed ID: 3403200
    [Abstract] [Full Text] [Related]

  • 2. Long-term immunosuppressive therapy of idiopathic membranoproliferative glomerulonephritis.
    Orlowski T, Rancewicz Z, Lao M, Juskowa J, Klepacka J, Gradowska L, Morzycka-Michalik M, Glyda J.
    Klin Wochenschr; 1988 Oct 17; 66(20):1019-23. PubMed ID: 3148785
    [Abstract] [Full Text] [Related]

  • 3. Membranous nephropathy: response to steroids and immunosuppression.
    Suki WN, Chavez A.
    Am J Nephrol; 1981 Oct 17; 1(1):11-6. PubMed ID: 7348534
    [Abstract] [Full Text] [Related]

  • 4. Controlled trial of monthly alternated courses of steroid and chlorambucil for idiopathic membranous nephropathy.
    Ponticelli C, Zucchelli P, Imbasciati E, Cagnoli L, Pozzi C, Grassi C, Limido D, Pasquali S, Passerini P, Volpini T, Locatelli F.
    Proc Eur Dial Transplant Assoc; 1983 Oct 17; 19():717-23. PubMed ID: 6348763
    [Abstract] [Full Text] [Related]

  • 5. [Programs of immunosuppressive and anti-inflammatory therapy of primary idiopathic glomerulonephritis. II. Membranous, membrano- proliferative and mesangial glomerulonephritis].
    Klinger M, Szewczyk Z.
    Przegl Lek; 1989 Oct 17; 46(12):816-21. PubMed ID: 2698488
    [No Abstract] [Full Text] [Related]

  • 6. Remission induced by chlorambucil in steroid-responsive, frequently relapsing nephrotic syndrome that relapsed after cyclophosphamide.
    Bailey RR.
    N Z Med J; 1989 Jul 26; 102(872):379-81. PubMed ID: 2797556
    [Abstract] [Full Text] [Related]

  • 7. Preserving renal function in patients with membranous nephropathy: daily oral chlorambucil compared with intermittent monthly pulses of cyclophosphamide.
    Reichert LJ, Huysmans FT, Assmann K, Koene RA, Wetzels JF.
    Ann Intern Med; 1994 Sep 01; 121(5):328-33. PubMed ID: 8042821
    [Abstract] [Full Text] [Related]

  • 8. [Cytostatic treatment of the steroid-resistant nephrotic syndrome. (Long term study on 24 patients)].
    Oechslen D, Kluthe R, Sarre H.
    Arch Klin Med; 1968 Sep 01; 215(2):150-60. PubMed ID: 5718136
    [No Abstract] [Full Text] [Related]

  • 9. Treatment of lupus nephritis.
    Pollak VE.
    Adv Nephrol Necker Hosp; 1976 Sep 01; 6():137-61. PubMed ID: 828444
    [No Abstract] [Full Text] [Related]

  • 10. Cytostatic treatment of glomerular diseases. V. Treatment of glomerulonephritis with cyclophosphamide plus prednisone, azathioprine plus prednisone and cyclophosphamide as monotherapy. A comparative study. A report from a Copenhagen Study Group of Renal Diseases.
    Brahm M, Balsløv JT, Brammer M, Brun C, Gerstoft J, Jørgensen HE, Kamper A, Larsen S, Lorenzen I, Thomsen AC.
    Acta Med Scand; 1988 Sep 01; 224(6):605-10. PubMed ID: 3061292
    [Abstract] [Full Text] [Related]

  • 11. [Primary chronic glomerulonephritis with nephrotic syndrome. Treatment with prednisone and cyclophosphamide].
    Knotková V, Nĕmecek K, Tarayeva IE, Krasnova TN.
    Vnitr Lek; 1993 Dec 01; 39(12):1157-63. PubMed ID: 8310664
    [Abstract] [Full Text] [Related]

  • 12. Treatment of childhood prednisone-resistant nephrotic syndrome and focal segmental glomerulosclerosis with intravenous methylprednisolone and oral alkylating agents.
    Griswold WR, Tune BM, Reznik VM, Vazquez M, Prime DJ, Brock P, Mendoza SA.
    Nephron; 1987 Dec 01; 46(1):73-7. PubMed ID: 3600915
    [Abstract] [Full Text] [Related]

  • 13. Predicting the response to cytotoxic therapy for childhood nephrotic syndrome: superiority of response to corticosteroid therapy over histopathologic patterns.
    Schulman SL, Kaiser BA, Polinsky MS, Srinivasan R, Baluarte HJ.
    J Pediatr; 1988 Dec 01; 113(6):996-1001. PubMed ID: 3193322
    [Abstract] [Full Text] [Related]

  • 14. [Cyclophosphamide pulse therapy in patients with primary glomerulonephritis].
    Rutkowski B, Wielgosz A, Manitius J, Bułło B, Kowalewska J, Tylicki L, Roszkiewicz A.
    Przegl Lek; 2000 Dec 01; 57(11):624-7. PubMed ID: 11293209
    [Abstract] [Full Text] [Related]

  • 15. Methylprednisolone plus chlorambucil as compared with methylprednisolone alone for the treatment of idiopathic membranous nephropathy. The Italian Idiopathic Membranous Nephropathy Treatment Study Group.
    Ponticelli C, Zucchelli P, Passerini P, Cesana B.
    N Engl J Med; 1992 Aug 27; 327(9):599-603. PubMed ID: 1640953
    [Abstract] [Full Text] [Related]

  • 16. Combination therapy with rituximab, low-dose cyclophosphamide, and prednisone for idiopathic membranous nephropathy: a case series.
    Cortazar FB, Leaf DE, Owens CT, Laliberte K, Pendergraft WF, Niles JL.
    BMC Nephrol; 2017 Feb 01; 18(1):44. PubMed ID: 28143416
    [Abstract] [Full Text] [Related]

  • 17. Controlled trial of methylprednisolone and chlorambucil in idiopathic membranous nephropathy.
    Ponticelli C, Zucchelli P, Imbasciati E, Cagnoli L, Pozzi C, Passerini P, Grassi C, Limido D, Pasquali S, Volpini T.
    N Engl J Med; 1984 Apr 12; 310(15):946-50. PubMed ID: 6366560
    [Abstract] [Full Text] [Related]

  • 18. [Effect of immunosuppressive, anticoagulant and anti-inflammatory agents on experimental glomerulonephritis. VI. Encorton, immuran and cyclophosphamide].
    Tyszkiewicz Z, Gawlik Z, Lewandowska T, Juska D.
    Patol Pol; 1984 Apr 12; 35(1):105-14. PubMed ID: 6493817
    [No Abstract] [Full Text] [Related]

  • 19. Chlorambucil treatment of frequently relapsing nephrotic syndrome.
    Grupe WE, Makker SP, Ingelfinger JR.
    N Engl J Med; 1976 Sep 30; 295(14):746-9. PubMed ID: 958261
    [Abstract] [Full Text] [Related]

  • 20. ACTH and azathioprine: antiproteinuric and lipid-lowering effect in the course of idiopathic membranous glomerulonephritis.
    Gigante A, Rosato E, Liberatori M, Gasperini ML, Giannakakis K, Barbano B, Cianci R, Salsano F, Amoroso A.
    J Biol Regul Homeost Agents; 2012 Sep 30; 26(1):135-8. PubMed ID: 22475105
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.